Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Biogen Inc. Transaction History

Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group

$255 Billion
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2016 Sep 04, 2024	SELL	N/A	-40,000 Closed	0 $0
Q2 2016 Sep 04, 2024	BUY	N/A	40,000	40,000 $9.67 Billion

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.28 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.23 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.87 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.4 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.12 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group, based on Form 13F filings with the SEC.

News

Stay updated on Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group with notifications on news.

Account